These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 179696)

  • 1. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papilloma virus in cervical carcinoma: detection of viral antigen in cancer cells.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1992; 6(1-2):41-53. PubMed ID: 1320667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
    Smith CC; Aurelian L; Gupta PK; Frost JK; Rosenshein NB; Klacsmann K; Geddes S
    Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies in patients with cervicouterine carcinoma].
    Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
    Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with herpes-simplex viruses 1 and 2. II.
    Nahmias AJ; Roizman B
    N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and biochemical characterization of individual polypeptides induced by herpes simplex virus types 1 and 2.
    Courtney RJ
    Adv Pathobiol; 1976; (5):87-103. PubMed ID: 220860
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural history of precancerous and early cancerous lesions of the uterine cervix.
    Luthra UK; Prabhakar AK; Seth P; Agarwal SS; Murthy NS; Bhatnagar P; Das DK; Sharma BK
    Acta Cytol; 1987; 31(3):226-34. PubMed ID: 3035845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
    Freymuth F; Morel C; Longson A; Tanguy M
    Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody to HSV2 protein as an immunodiagnostic marker in cervical cancer.
    Costa S; D'Errico A; Grigioni WF; Orlandi C; Smith CC; Mancini AM; Aurelian L
    Cancer Detect Prev Suppl; 1987; 1():189-205. PubMed ID: 2826000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral etiology of cervical carcinoma. Human papilloma virus and herpes simplex virus type 2.
    Meng XJ; Sun Y; Chen MH; Liu ZH; Zhang YX; Li XZ; Li K; Han RC; Si JY; Hu LY
    Chin Med J (Engl); 1989 Feb; 102(2):94-9. PubMed ID: 2550184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.